|
Current issue
Archive
Online First
About the journal
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Special Issues
Instructions for authors
Publication charge
Editorial System
Submit your Manuscript
Open access 
|
5/2010
vol. 9 abstract:
Original paper
Characteristics of breast cancer patients with pathological complete response after neoadjuvant chemotherapy
Agnieszka Kołacińska
,
Maria Błasińska-Morawiec
,
Izabela Dowgier-Witczak
,
Radzisław Kordek
,
Zbigniew Morawiec
Przegląd Menopauzalny 2010; 5: 300–304
Online publish date: 2010/10/27
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Objectives : Pathological complete response (pCR) after neoadjuvant systemic treatment, used in inoperable locally advanced breast cancers or resectable tumours with the intent to reduce their size, is defined as no residual cancer in the breast and axilla reported by the pathologist.
Aim : The aim of the study is to characterize breast cancer patients who achieved pathological complete response after neoadjuvant systemic treatment. Material and methods : 101 consecutive patients with locally advanced breast cancer, operated on after adjuvant systemic treatment, were enrolled in the study. Results : 8.91% of patients achieved a pCR. Conclusions : The highest rate of pCR was observed in triple negative breast cancer patients, G3, with invasive ductal carcinoma, receiving a combination of anthracycline- and taxane-based chemotherapy. keywords:
breast cancer, pathological complete response, preoperative systemic treatment |
 |
